Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy

American Journal of Health-System Pharmacy

Volumn 65, Issue 11, 2008, Pages 1048-1050

  Barbosa, Leandro A ^a   Teixeira, Carlos Roberto V ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Anticonvulsants; Dexamethasone; Erythema multiforme; Neoplasm metastasis; Phenytoin; Radiation; Ranitidine; Seizures; Toxicity

Indexed keywords

ANTICONVULSIVE AGENT; DEXAMETHASONE; FLUCONAZOLE; PHENYTOIN; RANITIDINE; SULFIRAM; VANCOMYCIN;

ADULT; ARTICLE; BRAIN METASTASIS; BREAST ADENOCARCINOMA; CASE REPORT; DISEASE ASSOCIATION; ERYTHEMA MULTIFORME; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE; SEIZURE; TOXIC EPIDERMAL NECROLYSIS;

EID: 44449178803     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060580     Document Type: Article

References (17)

1. Chan HL, Stern RS, Kenneth AA et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990; 126:43-7.
2. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983; 8:763-75.
3. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol. 1994; 102:28S-30S.
4. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
5. Rapp RP, Norton JA, Young B et al. Cutaneous reactions in head-injured patients receiving phenytoin for seizure prophylaxis. Neurosurgery. 1983; 13:272-5.
6. Ahmed I, Reichenberg J, Lucas A et al. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol. 2004; 43:67-73.
7. Wörhl S, Loewe R, Pickl WF et al. EMPACT syndrome. J Dtsch Dermatol Ges. 2005; 3:39-43.
8. Uçgun R, Metintafl M, Kolsuz M et al. Toxic epidermal necrolysis associated with phenytoin and cranial irradiation in small-cell lung cancer. Turk Respir J. 2001; 2:28-30.
9. Khafaga YM, Jamshed A, Allam AA et al. Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy. Acta Oncol. 1999; 38:111-6.
10. Topkan E, Zorlu F, Gürkaynak M. Stevens-Johnson syndrome in patients receiving cranial irradiation and concomitant diphenylhydantoin. Turk J Cancer. 2002; 32:164-71.
11. Aydin F, Cokluk C, Senturk N et al. Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin. J Eur Acad Dermatol Venereol. 2006; 20:588-90.
12. Maxfield WS, Coleman WP. Cutaneous reactions after radiation therapy. Report of 7 cases. Am J Roentgenol Radium Ther Nucl Med. 1969; 105:636-45.
13. Rzany B, Correia O, Kelly JP et al. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet. 1999; 353:2190-4.
14. Lin MS, Dai YS, Pwu RF et al. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J. 2005; 35:188-90.
15. Baba M, Karakas M, Aksungur VL et al. The anticonvulsant hypersensitivity syndrome. J Eur Acad Dermatol Venereol. 2003; 17:399-401.
16. Delattre JY, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology. 1988; 38:194-8.
17. Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 54:1886-93.